Switch to
More onapp

How to use scorecard? Learn more

Vilin Bio Med Ltd

VILINBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹29 cr, stock is ranked 3,839
High RiskStock is 5.86x as volatile as Nifty
21.500.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹29 cr, stock is ranked 3,839
High RiskStock is 5.86x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
1.31
Dividend YieldDiv. Yield
Sector PESector PE
51.44
Sector PBSector PB
6.57
Sector Div YldSctr Div Yld
0.51%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vilin Bio Med Limited engages in manufacturing pharmaceutical products, offering a range of dyes, pigment paste, and FMCG items.

Financial TrendFinancial statements 

202120222023202411.7211.2112.3316.120.120.021.220.15
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events